Stock listing

NASDAQ:NBSE NeuBase Therapeutics Inc Stock

Follow NeuBase Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:NBSE

$0.378 USD

Close on May 24, 2024 · No longer trades

Jun 15, 2023 to last close -86.1% · daily closes, Jun 15, 2023 – May 24, 2024
Lowest – highest close
$0.378 – $3.050 USDSince Jun 15, 2023 · lowest May 10, 2024 · highest Jun 20, 2023

Delisted NASDAQ:NBSE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NBSE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Eric I Richman
Other companies: Gain Therapeutics, Inc. (Director · Since at least Mar 17, 2021); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past)
Director · Jul 12, 2019 – Sep 9, 2022 · Past
Eric J Ende
Other companies: Avadel Pharmaceuticals PLC (Director · Since at least May 27, 2022); Matinas BioPharma Holdings, Inc. (Director · Nov 14, 2022 – Nov 1, 2023 · Past)
Director · Sep 9, 2022 – Sep 9, 2022 · Past
Dietrich A StephanFounder and CEO, Director · Jul 12, 2019 – Aug 2, 2023 · Past
Gerald J McDougallDirector · May 11, 2021 – Sep 9, 2022 · Past
Irach B TaraporewalaChief Executive Officer, Director · Jun 13, 2013 – Mar 10, 2015 · Past
William Roland MannChief Operating Officer · Apr 26, 2021 – Mar 30, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about NeuBase Therapeutics Inc.